Jianqing Lin

2.9k total citations
62 papers, 1.7k citations indexed

About

Jianqing Lin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jianqing Lin has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Jianqing Lin's work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Cancer, Lipids, and Metabolism (10 papers). Jianqing Lin is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Cancer, Lipids, and Metabolism (10 papers). Jianqing Lin collaborates with scholars based in United States, China and Singapore. Jianqing Lin's co-authors include Michael R. Freeman, Rosalyn M. Adam, Michael A. Carducci, William Kevin Kelly, Edouard J. Trabulsi, Jean Hoffman‐Censits, Costas D. Lallas, Sushant K. Kachhap, Srinivasan Yegnasubramanian and Senthamil R. Selvan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jianqing Lin

60 papers receiving 1.7k citations

Peers

Countries citing papers authored by Jianqing Lin

Since Specialization

Citations

This map shows the geographic impact of Jianqing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqing Lin more than expected).

Fields of papers citing papers by Jianqing Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqing Lin. The network helps show where Jianqing Lin may publish in the future.

Co-authorship network of co-authors of Jianqing Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqing Lin. A scholar is included among the top collaborators of Jianqing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqing Lin. Jianqing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aggressive Infection by K1/ST1265 Klebsiella pneumoniae Leading to Multiple Abscesses: Case Report and Literature Review 2025 ·Infection and Drug Resistance ·(unknown), (unknown), Ye Lu, Jianqing Lin, Liping Xu	1
2	Association between neutrophil percentage-to-albumin ratio and breast cancer in adult women in the US: findings from the NHANES 2025 ·Frontiers in Nutrition ·(unknown), (unknown), Jiayi Wang, Jianqing Lin	3
3	Celecoxib paradoxically induces COX-2 expression and astrocyte activation through the ERK/JNK/AP-1 signaling pathway in the cerebral cortex of rats 2024 ·Neurochemistry International ·Kai‐Che Wei, Jianqing Lin, Chia-Ho Lin	0
4	Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer 2024 ·Scientific Reports ·Qiao‐Nan Guo, (unknown), (unknown), (unknown), (unknown), Jianqing Lin	3
5	Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Jianqing Lin	0
6	Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer 2023 ·Prostate Cancer and Prostatic Diseases ·Zhenchao Zhang, Rui Luo, William Kevin Kelly, Joshua Chen, (unknown), (unknown), Nathan Handley, William Tester, (unknown), (unknown), Ronald E. Myers, Grace L. Lu‐Yao, Jian Gu, Jianqing Lin, Bingshan Li, Chun Wang, Hushan Yang	2
7	ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma 2022 ·Frontiers in Oncology ·Weigang Qiu, Xinquan Wu, Haihong Shi, Bingyang Liu, Liqiong Li, (unknown), Jianqing Lin	7
8	Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer 2021 ·The Oncologist ·Jianqing Lin, (unknown), (unknown), Erica Palmer, Christian Zevallos‐Delgado, Satish Noonepalle, (unknown), Robert D. Siegel, Yan Ma, Alejandro Villagra	12
9	Cardiovascular Toxicity of Androgen Deprivation Therapy 2021 ·Current Cardiology Reports ·(unknown), (unknown), (unknown), Jianqing Lin	19
10	Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Jianqing Lin, Robert B. Den, J S Greenspan, Timothy N. Showalter, Jean Hoffman‐Censits, Costas D. Lallas, Edouard J. Trabulsi, Leonard G. Gomella, Mark Hurwitz, Benjamin E. Leiby, Adam P. Dicker, William Kevin Kelly	2
11	Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies 2016 ·Current Cancer Drug Targets ·Senthamil R. Selvan, John P. Dowling, William Kevin Kelly, Jianqing Lin	61
12	Pazopanib Induces Retinal Tear: A Case Report 2015 ·Jianqing Lin, (unknown)	1
13	Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel–prednisone in metastatic castration-resistant prostate cancer 2015 ·Investigational New Drugs ·Daniel P. Petrylak, (unknown), William R. Clark, Elisabeth I. Heath, Jianqing Lin, William Oh, David B. Agus, Bradley Curtis Carthon, Susan Moran, Ning Kong, Ajit Suri, (unknown), Glenn Liu	12
14	Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity 2014 ·Journal of Clinical Oncology ·Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo, Edouard J. Trabulsi, Eric A. Ross, Richard E. Greenberg, David Y.T. Chen, Costas D. Lallas, Yu-Ning Wong, Jianqing Lin, Alexander Kutikov, Efrat Dotan, Timothy Brennan, Norma Alonzo Palma, Essel Dulaimi, Reza Mehrazin, Stephen A. Boorjian, William Kevin Kelly, Robert G. Uzzo, Gary R. Hudes	192
15	The Dilemma of a Rising Prostate-Specific Antigen Level After Local Therapy: What Are Our Options? 2013 ·Seminars in Oncology ·Nicholas G. Zaorsky, Ganesh V. Raj, Edouard J. Trabulsi, Jianqing Lin, Robert B. Den	29
16	Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor 2010 ·PLoS ONE ·Sushant K. Kachhap, (unknown), Spencer J. Collis, Madeleine S.Q. Kortenhorst, Michel D. Wissing, Mohammad Hedayati, Shabana Shabbeer, Janet Mendonca, (unknown), Luigi Marchionni, Jianqing Lin, Naseruddin Höti, J.W.R. Nortier, Theodore L. DeWeese, Hans J. Hammers, Michael A. Carducci	134
17	HIF-1α and Calcium Signaling as Targets for Treatment of Prostate Cancer by Cardiac Glycosides 2009 ·Current Cancer Drug Targets ·Jianqing Lin, S. Denmeade, Michael A. Carducci	35
18	Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells 2002 ·The Prostate ·Jianqing Lin, Michael R. Freeman	42
19	BAG-1 Is a Novel Cytoplasmic Binding Partner of the Membrane Form of Heparin-binding EGF-like Growth Factor 2001 ·Journal of Biological Chemistry ·Jianqing Lin, Lloyd Hutchinson, Sandra M. Gaston, Gerhard Raab, Michael R. Freeman	62
20	Heparin-Binding EGF-Like Growth Factor Is Up-Regulated in the Obstructed Kidney in a Cell- and Region-Specific Manner and Acts to Inhibit Apoptosis 2000 ·American Journal Of Pathology ·Hiep T. Nguyen, (unknown), Abdelbasset A. Badawy, Rosalyn M. Adam, Jianqing Lin, Anna Orsola, Paul D. Guthrie, Michael R. Freeman, Craig A. Peters	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact